Oncotarget

Research Papers:

Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas

Antoine M. Snijders _, Yueyong Liu, Li Su, Yurong Huang and Jian-Hua Mao

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:44794-44805. https://doi.org/10.18632/oncotarget.6328

Metrics: PDF 624 views  |   HTML 1221 views  |   ?  


Abstract

Antoine M. Snijders1, Yueyong Liu1,2, Li Su1, Yurong Huang1, Jian-Hua Mao1

1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA

2Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Correspondence to:

Antoine M Snijders, e-mail: AMSnijders@lbl.gov

Jian-Hua Mao, e-mail: JHMao@lbl.gov

Keywords: thymic lymphoma, FBXW7, mTOR, rapamycin, radiation

Received: July 16, 2015     Accepted: October 23, 2015     Published: November 02, 2015

ABSTRACT

The tumor suppressor gene FBXW7 is deleted and mutated in many different types of human cancers. FBXW7 primarily exerts its tumor suppressor activity by ubiquitinating different oncoproteins including mTOR. Here we used gene transcript profiling to gain a deeper understanding of the role of FBXW7 in tumor development and to determine the influence of mTOR inhibition by rapamycin on tumor transcriptome and biological functions. In comparison to tumors from p53 single heterozygous (p53+/−) mice, we find that radiation-induced thymic lymphomas from Fbxw7/p53 double heterozygous (Fbxw7+/−p53+/−) mice show significant deregulation of cholesterol metabolic processes independent of rapamycin treatment, while cell cycle related genes were upregulated in tumors from placebo treated Fbxw7+/−p53+/− mice, but not in tumors from rapamycin treated Fbxw7+/−p53+/− mice. On the other hand, tumors from rapamycin treated Fbxw7+/−p53+/− mice were enriched for genes involved in the integrated stress response, an adaptive mechanism to survive in stressful environments. Finally, we demonstrated that the Fbxw7 gene signatures identified in mouse tumors significantly overlap with FBXW7 co-expressed genes in human cancers. Importantly these common FBXW7 gene signatures between mouse and human are predictive for disease-free survival in human colon, breast and lung adenocarcinoma cancer patients. These results provide novel insights into the role of FBXW7 in tumor development and have identified a number of potential targets for therapeutic intervention.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6328